Back to KROS
AQR CAPITAL MANAGEMENT LLC → KROS
AQR CAPITAL MANAGEMENT LLC KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
24
Latest value
$109K
Q3 2026
Peak value
$10.2M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $4.5M |
| Q1 2026 | $77 |
| Q1 2026 | $3K |
| Q1 2026 | $6K |
| Q1 2026 | $640 |
| Q1 2026 | $17K |
| Q1 2026 | $386 |
| Q2 2026 | $20K |
| Q2 2026 | $86 |
| Q2 2026 | $10.2M |
| Q2 2026 | $5K |
| Q2 2026 | $3K |
| Q2 2026 | $118 |
| Q2 2026 | $99K |
| Q3 2026 | $160 |
| Q3 2026 | $19K |
| Q3 2026 | $2K |
| Q3 2026 | $9M |
| Q3 2026 | $7K |
| Q3 2026 | $399 |
| Q3 2026 | $80 |
| Q3 2026 | $171 |
| Q3 2026 | $547 |
| Q3 2026 | $109K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $109K | 9.6K | — | — |
| Q3 2026 | $547 | 48 | — | — |
| Q3 2026 | $171 | 15 | — | — |
| Q3 2026 | $80 | 7 | — | — |
| Q3 2026 | $399 | 35 | — | — |
| Q3 2026 | $7K | 648 | — | — |
| Q3 2026 | $9M | 791.7K | — | — |
| Q3 2026 | $2K | 214 | — | — |
| Q3 2026 | $19K | 1.7K | — | — |
| Q3 2026 | $160 | 14 | — | — |
| Q2 2026 | $99K | 9.2K | — | — |
| Q2 2026 | $118 | 11 | — | — |
| Q2 2026 | $3K | 268 | — | — |
| Q2 2026 | $5K | 436 | — | — |
| Q2 2026 | $10.2M | 956.1K | — | — |
| Q2 2026 | $86 | 8 | — | — |
| Q2 2026 | $20K | 1.9K | — | — |
| Q1 2026 | $386 | 35 | — | — |
| Q1 2026 | $17K | 1.5K | — | — |
| Q1 2026 | $640 | 58 | — | — |
| Q1 2026 | $6K | 538 | — | — |
| Q1 2026 | $3K | 245 | — | — |
| Q1 2026 | $77 | 7 | — | — |
| Q1 2026 | $4.5M | 404.1K | — | — |